Modulation of the PI3K/mTOR pathways
- 1 January 2020
- book chapter
- Published by Elsevier
- p. 89-105
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway AlterationsCancer Cell, 2017
- Combination of mTOR and EGFR targeting in an orthotopic xenograft model of head and neck cancerThe Laryngoscope, 2015
- Drugging PI3K in cancer: refining targets and therapeutic strategiesCurrent Opinion in Pharmacology, 2015
- Targeting the PI3K Pathway in Head and Neck Squamous Cell CarcinomaAmerican Society of Clinical Oncology Educational Book, 2015
- Comprehensive genomic characterization of head and neck squamous cell carcinomasNature, 2015
- PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targetingNature Reviews Cancer, 2014
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathwayPharmacology & Therapeutics, 2014
- Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive BiomarkersCancer Discovery, 2013
- Targeting PI3K signalling in cancer: opportunities, challenges and limitationsNature Reviews Cancer, 2009
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009